JUN 08, 2016 12:30 PM PDT
Laboratory reimbursement and other regulatory issues
SPONSORED BY: American Society for Clinical Laboratory Science (ASCLS)
CONTINUING EDUCATION (CME/CE/CEU) CREDITS: P.A.C.E. CE
4 9 367

Speakers:
  • Executive Vice President Emeritus, ASCLS
    Biography
      Elissa Passiment is the Executive Vice President of the American Society for Clinical Laboratory Science (ASCLS). She is a clinical laboratory scientist with over twenty years experience in clinical laboratories as staff, educator and manager and another twenty years in health care consulting, association management and health policy. Ms. Passiment uses her science background and experience to analyze policies and systems as they relate to the future of health care, its changing emphasis, reimbursement, patient safety, quality delivery and business potential. She has served on the congressionally mandated Negotiated Rulemaking Committee convened to standardize and simplify reimbursement for laboratory services under Medicare Part B; presented testimony to Institute of Medicine studies, and represents ASCLS at meetings with the FDA, CMS, and CDC. She is also on the Editorial Board of Lab Tests Online. She was a member of the Clinical Laboratory Improvement Advisory Committee (CLIAC) from 2007-2011 and served as Chair for 2009-11. She is the recipient of numerous awards, including the Laboratory Public Service National Leadership Award.

    Abstract:
    The Centers for Medicare and Medicaid Services (CMS) is about to gather reimbursement data from laboratories to recalculate the clinical laboratory fee schedule.  The process and potential impact of this project, as well as  other new reimbursement models proposed by CMS will be discussed.  We will also update attendees on the FDA laboratory developed test guidance and controversy, describe the status of CLIA activities and analyze federal government policy developments pertaining to laboratory practice.
     

    Show Resources
    Loading Comments...